Document 0099
 DOCN  M9440099
 TI    Management of chronic hepatitis in special populations.
 DT    9404
 AU    Lindsay KL; Department of Medicine, University of Southern California,
       Los; Angeles 90033.
 SO    Am J Med. 1994 Jan 17;96(1A):57S-60S. Unique Identifier : AIDSLINE
       MED/94152661
 AB    Over the last several years, much progress has been made in the
       treatment of adult patients with chronic viral hepatitis and compensated
       liver disease in the absence of significant other illnesses. However,
       the treatment of chronic viral hepatitis in other patient populations is
       still experimental. These groups include children, patients
       immunocompromised by human immunodeficiency virus infection or
       immunosuppression following organ transplantation, those with end-stage
       renal disease, and patients with extrahepatic manifestations of
       hepatitis viral infection. Data on the treatment of chronic hepatitis in
       these special populations are reviewed.
 DE    Child  Chronic Disease  Hepatitis, Viral, Human/COMPLICATIONS/*THERAPY
       Human  HIV Infections/COMPLICATIONS  Immunosuppression  Kidney Failure,
       Chronic/COMPLICATIONS  JOURNAL ARTICLE  REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).